MLICM
ALT icon

Metropolitan Life Insurance Company (MetLife)’s Altimmune ALT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,727
Closed -$27.8K – 105
2024
Q1 		$27.8K Hold
2,727
– – ﹤0.01% 1695
2023
Q4 		$30.7K Hold
2,727
– – ﹤0.01% 1709
2023
Q3 		$7.09K Hold
2,727
– – ﹤0.01% 2352
2023
Q2 		$9.63K Buy
+2,727
New +$12.2K ﹤0.01% 2316
2022
Q2 		– Sell
-2,806
Closed -$17.1K – 2370
2022
Q1 		$17.1K Sell
2,806
-8,245
-75% -$60.7K ﹤0.01% 2159
2021
Q4 		$101K Buy
11,051
+898
+9% +$9.54K ﹤0.01% 2469
2021
Q3 		$115K Buy
10,153
+354
+4% +$4.3K ﹤0.01% 2447
2021
Q2 		$96.5K Buy
+9,799
New +$134K ﹤0.01% 2604

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ALT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Altimmune (ALT) in Q2 2024, closing a stake of 2,727 shares — an estimated $27.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ALT in Q2 2021 and held it in 8 quarters. The position peaked at $115K in Q3 2021. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,727 Altimmune shares in Q2 2024, an estimated $27.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Altimmune in Q2 2021 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Altimmune position peaked at $115K in Q3 2021.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.